Crwepicks Stock Reports; Pwrm, Xprt, Life, Genz
Power3 Medical Products, Inc
Power3 Medical Products, Inc. (OTCBB: PWRM) announced that, in collaboration with Lourdes R. Bosquez, MD, it has unexpectedly discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro protein biomarkers in the blood of untreated Alzheimer"s disease patients compared to patients treated with the widely used anti-dementia drugs Aricept (Donepezil HCl, Pfizer "" NYSE: PFE), Exelon (Rivastigmine, Novartis "" NYSE: NVS), and Namenda (Memantine HCl, Forest Laboratories "" NYSE: FRX). These results relate to the genetically distinct groups of Alzheimer"s disease patients, i.e., those individuals who possess the Alzheimer"s high-risk gene for Apolipoprotein E4 and those who do not possess the gene.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer"s disease and Parkinson"s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig"s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro"", a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a serum test for the detection of neurodegenerative diseases, including Alzheimer"s, Parkinson"s and ALS diseases, currently engaged in Phase II clinical trials. These products are designed to analyze proteins and their mutations to assess an individual"s risk for developing disease later in life, a patient"s likelihood of responding to a particular drug, a patient"s risk of disease progression and disease recurrence, to measure a patient"s exposure to drug therapy, to ensure optimal dosing and reduced drug toxicity.
For more information, please visit http://www.power3medical.com.
LECG Corporation (NASDAQ:XPRT), a global business advisory and professional services firm, announced it has signed a definitive agreement to acquire Bourne, a London-based independent business consultancy practice. Subject to customary conditions, the parties expect the closing of the acquisition to occur on July 2, 2010. This acquisition will add 36 people to LECG"s UK base, expanding LECG"s European presence to include specialists in valuation, transfer pricing, IP and tax consulting and advice as an extension to its finance, risk, process and operations services currently provided by its financial services practice. Bourne is a perfect fit for the new LECG as it seamlessly extends and enhances our disputes, valuation, IP and international tax practices.
LECG is a global expert services and consulting firm with approximately 1100 experts and professionals in 39 global locations. The firm provides independent expert testimony, financial advisory services, original authoritative studies, strategic advisory, governance, assurance and tax, and business consulting services to clients including Fortune Global 500 corporations, major law firms, and local, state, and federal governments and agencies in the U.S., Central and South America, Europe, and Asia-Pacific.
LECG"s highly credentialed experts and professional staff conduct economic and financial analyses to provide objective opinions and advice regarding complex disputes and inform legislative, judicial, regulatory, and business decision makers. In addition, the firm assists clients in major sectors with compliance and business process improvement consulting. LECG"s experts are renowned academics, former senior government officials, experienced industry leaders, and seasoned consultants. (NASDAQ:XPRT).
For more information, visit www.lecg.com.
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, announced activities and product launches in concert with the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting that highlight the company"s offerings of complete end-to-end solutions for stem cell research. Stem cell research has been shown to be a critical component of regenerative medicine; a basis for identifying drug targets and drug screening; and an important step in the development of therapies to treat a variety of diseases.
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference.
Please visit our website: http://www.lifetechnologies.com.
Genzyme Corporation (NASDAQ: GENZ) announced that it has entered into an agreement with Goldman, Sachs & Co. to repurchase $1 billion of Genzyme common stock under an accelerated stock repurchase program. Proceeds from its recently concluded debt offering will be used to support this first tranche of Genzyme"s overall $2 billion share repurchase plan announced in May.
Genzyme Corporation is one of the world"s leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 12,000 employees in locations spanning the globe and 2009 revenues of $4.5 billion. In 2010, Genzyme was named to the Fortune 500.
For more information visit: www.genzyme.com
*******************************************
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
*******************************************
business Card 3
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations.Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB)
by: Blayne Sheffield
Useful And Important 4gb Sd Varieties of Sir Walter and Their Benefits How To Create Amazing Results And Be Successful In Life Planning A Father And Son Outing Pennytobuck.coms Stock Report On Pwrm, Forr, Siga, Sppi The Pros and Cons of a No Annual Fee Card The Inshore Model That Can Transform your Enterprise into an Agile and Competitive Entity What Are Twist Ties and How Are They More Useful Than Other Kinds of Ties Adhering to Surviving Earthquakes and Air Raids The Land Of The Rising Sun: Where Incredible Natural Landscapes And Bustling City Life Collide What Are Cable Ties and Why Are They So Important? Significant Things To Know About Va's Aid And Attendance Benefit Make Them Save Some and You too Make Something